Actively Recruiting

Phase 2
Age: 16Years +
All Genders
ID07015983

A Phase 2, Multicenter, Open-Label Study of CC-97540 (BMS-986353), CD19-Targeted NEX-T CAR T Cells, in Participants With Active SLE (Including Lupus Nephritis) With Inadequate Response to Glucocorticoids and at Least 2 Immunosuppressants (Breakfree-SLE)

Led by Juno Therapeutics, Inc., a Bristol-Myers Squibb Company · Updated on 2026-06-01

89

Participants Needed

95

Research Sites

212 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Researchers are evaluating the drug CC-97540 in people aged 16 and older who have active systemic lupus erythematosus (SLE), including lupus nephritis, and who have not responded well to glucocorticoids and at least two immunosuppressant treatments. This Phase 2 study aims to assess the effectiveness, safety, and drug levels of CC-97540 in this group. The study is sponsored by Juno Therapeutics, Inc., a Bristol-Myers Squibb Company. Participants will receive CC-97540, a type of CD19-targeted NEX-T CAR T cell therapy, along with specified doses of fludarabine and cyclophosphamide on scheduled days. The study is open-label and multicenter, meaning both participants and researchers know which treatment is given. The treatments are designed to evaluate disease control and remission in participants with inadequate prior responses. The study includes multiple assessments over a period of up to 60 months to monitor various health outcomes. Throughout the study, participants will be closely monitored with regular assessments, including measuring drug-free remission rates, kidney response in lupus nephritis cases, disease activity, and patient-reported outcomes like fatigue and pain. Laboratory tests will track kidney function, autoantibody levels, and immune system markers. Safety is carefully observed by recording adverse events and lab abnormalities. The total participation duration can last up to 60 months, allowing thorough evaluation of long-term effects and disease status.

CONDITIONS

Brief Title

A Study of CC-97540 (BMS-986353 or Zola-cel), CD19-Targeted NEX-T CAR T Cells, in Participants With Active SLE Despite Immunosuppressants (Breakfree-SLE)

Who Can Participate

Age: 16Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Participants must meet EULAR/ACR 2019 criteria for systemic lupus erythematosus (SLE).
  • Participants must have an inadequate response to appropriate doses of glucocorticoids and at least 2 immunosuppressant therapies, used for at least 3 months.
  • Participants must have active disease at the time of consent.
Not Eligible

You will not qualify if you...

  • Participants with other diseases, conditions, or treatments that could affect study results.
  • Participants with uncontrolled or significant cardiovascular or central nervous system conditions.
  • Participants with a history of malignancies or lymphoproliferative disease unless disease-free for at least 2 years, except certain non-invasive cancers.
  • Pregnant or breastfeeding individuals, or those planning pregnancy.
  • Participants with prior CAR T cell therapy, genetically modified T cell therapy, stem cell transplant, or organ transplant.
  • Participants who received live vaccines within 6 weeks before lymphodepleting chemotherapy.
  • Participants with inadequate organ function.
  • Other protocol-defined criteria may apply.

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

screening and enrollment visit

Treatment

Duration - Specified dosing days during the treatment period

Participants receive specified doses of CC-97540, Fludarabine, and Cyclophosphamide on specified days as part of the treatment for active SLE.

1 baseline visit and multiple treatment visits as per protocol

Follow-up

Duration - Up to 60 months

Participants are monitored for up to 60 months to assess remission status, kidney response, disease activity, and safety outcomes.

Regular follow-up visits over 5 years

Trial Site Locations

Total: 95 locations

1

Local Institution - 0106

Scottsdale, Arizona, United States, 85259

Not Yet Recruiting

2

Local Institution - 0038

Los Angeles, California, United States, 90027

Not Yet Recruiting

3

Local Institution - 0051

Los Angeles, California, United States, 90095

Not Yet Recruiting

4

Local Institution - 0093

Newport Beach, California, United States, 92663

Not Yet Recruiting

5

Lucile Packard Children's Hospital

Palo Alto, California, United States, 94304

Actively Recruiting

6

University of Colorado Anschutz Medical Campus

Aurora, Colorado, United States, 80045

Actively Recruiting

7

Local Institution - 0105

Denver, Colorado, United States, 80218

Not Yet Recruiting

8

Mayo Clinic in Florida

Jacksonville, Florida, United States, 32224

Actively Recruiting

9

University of Miami Hospital and Clinics, Sylvester Cancer Center

Miami, Florida, United States, 33136

Actively Recruiting

10

Local Institution - 0073

Orlando, Florida, United States, 32803

Not Yet Recruiting

11

Moffitt Cancer Center

Tampa, Florida, United States, 33612

Actively Recruiting

12

USF Health

Tampa, Florida, United States, 33612

Actively Recruiting

13

Florida Medical Clinic Orlando Health

Zephyrhills, Florida, United States, 33542

Actively Recruiting

14

Emory University School of Medicine

Atlanta, Georgia, United States, 30322

Actively Recruiting

15

Local Institution - 0079

Atlanta, Georgia, United States, 30322

Not Yet Recruiting

16

Northside Hospital

Atlanta, Georgia, United States, 30342

Actively Recruiting

17

Local Institution - 0108

Indianapolis, Indiana, United States, 46250

Not Yet Recruiting

18

Local Institution - 0086

Baton Rouge, Louisiana, United States, 70836

Not Yet Recruiting

19

Local Institution - 0110

Shreveport, Louisiana, United States, 71101

Not Yet Recruiting

20

Local Institution - 0094

Boston, Massachusetts, United States, 02114

Not Yet Recruiting

21

Local Institution - 0096

Ann Arbor, Michigan, United States, 48109

Not Yet Recruiting

22

Local Institution - 0011

Rochester, Minnesota, United States, 55905

Not Yet Recruiting

23

Atlantic Health System Overlook Medical Center

Summit, New Jersey, United States, 07901

Actively Recruiting

24

Local Institution - 0101

Manhasset, New York, United States, 11030

Not Yet Recruiting

25

Local Institution - 0082

New York, New York, United States, 10016

Not Yet Recruiting

26

Hospital for Special Surgery

New York, New York, United States, 10021

Actively Recruiting

27

Icahn School of Medicine at Mount Sinai

New York, New York, United States, 10029

Actively Recruiting

28

Columbia University Irving Medical Center

New York, New York, United States, 10032

Actively Recruiting

29

Local Institution - 0095

New York, New York, United States, 10032

Not Yet Recruiting

30

Weill Cornell Medical College

New York, New York, United States, 10065

Actively Recruiting

31

Local Institution - 0111

Stony Brook, New York, United States, 11794

Not Yet Recruiting

32

Carolinas HealthCare System SouthPark

Charlotte, North Carolina, United States, 28211

Actively Recruiting

33

Cincinnati Children's Hospital Medical Center

Cincinnati, Ohio, United States, 45229

Actively Recruiting

34

Cleveland Clinic

Cleveland, Ohio, United States, 44195

Actively Recruiting

35

Local Institution - 0083

Philadelphia, Pennsylvania, United States, 19104

Not Yet Recruiting

36

Baptist Memorial Hospital

Memphis, Tennessee, United States, 38120

Actively Recruiting

37

Baylor Scott and White Research Institute

Dallas, Texas, United States, 75246

Actively Recruiting

38

Local Institution - 0098

Dallas, Texas, United States, 75390-9068

Not Yet Recruiting

39

Local Institution - 0104

San Antonio, Texas, United States, 78229

Not Yet Recruiting

40

Swedish Medical Center

Seattle, Washington, United States, 98122

Actively Recruiting

41

Hospital Italiano de Buenos Aires

ABB, Buenos Aires F.D., Argentina, C1199ABB

Actively Recruiting

42

Hospital Aleman

Buenos Aires, Buenos Aires F.D., Argentina, C1118AAT

Actively Recruiting

43

Local Institution - 0107

Buenos Aires, Argentina, B1629ODT

Not Yet Recruiting

44

Local Institution - 0077

Córdoba, Argentina, X5016

Not Yet Recruiting

45

Medizinische Universität Wien

Vienna, State of Vienna, Austria, 1090

Actively Recruiting

46

Uniklinikum Salzburg

Salzburg, Austria, 5020

Actively Recruiting

47

UZ Leuven

Leuven, Vlaams-Brabant, Belgium, 3000

Actively Recruiting

48

Local Institution - 0021

São Paulo, São Paulo, Brazil, 01409-001

Not Yet Recruiting

49

Local Institution - 0058

São Paulo, São Paulo, Brazil, 01509-010

Not Yet Recruiting

50

Local Institution - 0022

São Paulo, Brazil, 05652-900

Not Yet Recruiting

51

Vancouver General Hospital

Vancouver, British Columbia, Canada, V5Z 1M9

Actively Recruiting

52

The Hospital for Sick Children

Toronto, Ontario, Canada, M5G 1X8

Actively Recruiting

53

Local Institution - 0099

Toronto, Ontario, Canada, M5T 2S8

Not Yet Recruiting

54

Local Institution - 0047

Copenhagen, Capital Region, Denmark, 2100

Not Yet Recruiting

55

Odense Universitetshospital

Odense, Region Syddanmark, Denmark, 5000

Actively Recruiting

56

Local Institution - 0081

Toulouse, Haute-Garonne, France, 31059

Not Yet Recruiting

57

CHU Montpellier Lapeyronie Hospital

Montpellier, Hérault, France, 34295

Actively Recruiting

58

Centre Hospitalier Universitaire de Rennes - Hôpital Pontchaillou

Rennes, France, 35033

Actively Recruiting

59

Local Institution - 0109

Strasbourg, France, 67098

Not Yet Recruiting

60

Pitie Salpetriere University Hospital

Paris, Île-de-France Region, France, 75013

Actively Recruiting

61

Universitätsklinikum Leipzig

Leipzig, Saxony, Germany, 04103

Actively Recruiting

62

Universitaetsklinikum Magdeburg

Magdeburg, Saxony-Anhalt, Germany, 39120

Actively Recruiting

63

Charité - Universitaetsmedizin Berlin - Campus Bejnamin Franklin

Berlin, Germany, 10117

Actively Recruiting

64

Universitaetsklinikum Koeln

Cologne, Germany, 50937

Actively Recruiting

65

Universitaetsklinikum Erlangen

Erlangen, Germany, 91054

Actively Recruiting

66

Local Institution - 0084

Herne, Germany, 44649

Not Yet Recruiting

67

Sheba Medical Center

Ramat Gan, Central District, Israel, 5262100

Actively Recruiting

68

Local Institution - 0042

Jerusalem, Israel, 9112001

Not Yet Recruiting

69

Fondazione Policlinico Universitario Agostino Gemelli IRCCS - Università Cattolica del Sacro Cuore

Rome, Lazio, Italy, 00168

Actively Recruiting

70

ASST Grande Ospedale Metropolitano Niguarda

Milan, Milano, Italy, 20162

Actively Recruiting

71

Local Institution - 0044

Rome, Roma, Italy, 00165

Not Yet Recruiting

72

Local Institution - 0070

Pisa, Tuscany, Italy, 56126

Not Yet Recruiting

73

Local Institution - 0055

Sapporo, Hokkaido, Japan, 0608648

Not Yet Recruiting

74

Yokohama City University Hospital

Yokohama, Kanagawa, Japan, 236-0004

Actively Recruiting

75

Juntendo University Hospital

Bunkyo-ku, Tokyo, Japan, 113-8431

Actively Recruiting

76

Keio university hospital

Shinjuku-ku, Tokyo, Japan, 1608582

Actively Recruiting

77

Chiba University Hospital

Chiba, Japan, 260-8677

Actively Recruiting

78

Kyushu University Hospital

Fukuoka, Japan, 812-8582

Actively Recruiting

79

Okayama University Hospital

Okayama, Japan, 700-8558

Actively Recruiting

80

Osaka Metropolitan University Hospital

Osaka, Japan, 545-8586

Actively Recruiting

81

Szpital Specjalistyczny nr 1 w Bytomiu

Bytom, Silesian Voivodeship, Poland, 41-902

Actively Recruiting

82

Narodowy Instytut Onkologii - Oddzial w Gliwicach

Gliwice, Silesian Voivodeship, Poland, 44-101

Actively Recruiting

83

Centro Hospitalar Universitário Lisboa Norte, E.P.E. - Hospital de Santa Maria

Lisbon, Lisbon District, Portugal, 1649-035

Actively Recruiting

84

Hospital Universitari Vall d'Hebron

Barcelona, Barcelona [Barcelona], Spain, 08035

Actively Recruiting

85

Hospital Sant Joan de Déu

Esplugues de Llobregat, Barcelona [Barcelona], Spain, 08950

Actively Recruiting

86

Local Institution - 0088

Donostia / San Sebastian, Gipuzkoa, Spain, 20014

Not Yet Recruiting

87

Hospital La Princesa

Madrid, Spain, 28006

Actively Recruiting

88

H.R.U Málaga - Hospital General

Málaga, Spain, 29011

Actively Recruiting

89

Hospital Clínico Universitario Virgen de la Arrixaca

Murcia, Spain, 30120

Actively Recruiting

90

Local Institution - 0061

London, London, City of, United Kingdom, NW1 2PG

Withdrawn

91

University College London Hospital

London, London, City of, United Kingdom, NW1 2PG

Actively Recruiting

92

King's College Hospital

London, London, City of, United Kingdom, SE5 9RL

Actively Recruiting

93

Local Institution - 0090

Metropolitan Borough of Wirral, Merseyside, United Kingdom, L63 4JY

Not Yet Recruiting

94

Derriford Hospital, University Hospitals Plymouth NHS Trust

Crownhill, Plymouth, United Kingdom, PL6 8DH

Actively Recruiting

95

Local Institution - 0091

Liverpool, United Kingdom, L9 7AL

Not Yet Recruiting

Loading map...

Research Team

B

BMS Clinical Trials Contact Center www.BMSClinicalTrials.com

F

First line of the email MUST contain NCT # and Site #.

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

TREATMENT

Number of Arms

1

Similar Trials

A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disea...

Antineutrophilic Cytoplasmic Antibody (ANCA)- Associated Vasculitis (AAV)

Actively Recruiting

21 locations

A Phase 1/2 Study of NKX019, a CD19 Chimeric Antigen Recepto...

Lupus Nephritis

Actively Recruiting

19 locations

Efficacy, Safety and Tolerability of Cenerimod in Adults Wit...

Nephritis, Lupus

Actively Recruiting

10 locations

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here